Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

P-glycoprotein inhibitor

DRUG CLASS:

P-glycoprotein inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

oral paclitaxel/encequidar (1)

tetrandrine (0)

BAY 59-8862 (0)

oral paclitaxel/encequidar (1)

tetrandrine (0)

BAY 59-8862 (0)

›

HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	oral paclitaxel/encequidar Sensitive: B - Late Trials oral paclitaxel / encequidar Sensitive : B	oral paclitaxel/encequidar Sensitive: B - Late Trials oral paclitaxel / encequidar Sensitive : B
ABCG2 expression	Colorectal Cancer	ABCG2 expression	Colorectal Cancer	sunitinib + GF120918 Sensitive: D – Preclinical sunitinib + GF120918 Sensitive : D	sunitinib + GF120918 Sensitive: D – Preclinical sunitinib + GF120918 Sensitive : D
ABCB1 expression	Colorectal Cancer	ABCB1 expression	Colorectal Cancer	sunitinib + GF120918 Sensitive: D – Preclinical sunitinib + GF120918 Sensitive : D	sunitinib + GF120918 Sensitive: D – Preclinical sunitinib + GF120918 Sensitive : D